The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $120.81

Today's change+0.09 +0.07%
Updated March 30 11:20 AM EDT. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $120.81

Today's change+0.09 +0.07%
Updated March 30 11:20 AM EDT. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc up slightly

Alexion Pharmaceuticals Inc is up just (U.S.)$0.09 today to (U.S.)$120.81. Over the last five days, shares have gained 0.46%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 25.21% during the last year.

Key company metrics

  • Open(U.S.) $120.70
  • Previous close(U.S.) $120.72
  • High(U.S.) $122.93
  • Low(U.S.) $120.00
  • Bid / Ask(U.S.) $120.81 / (U.S.) $120.86
  • YTD % change-1.26%
  • Volume556,807
  • Average volume (10-day)1,684,146
  • Average volume (1-month)1,924,657
  • Average volume (3-month)2,457,986
  • 52-week range(U.S.) $109.12 to (U.S.) $162.00
  • Beta1.34
  • Trailing P/E68.65×
  • P/E 1 year forward22.99×
  • Forward PEG1.23×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.76
Updated March 30 11:20 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.03%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue831799753701
Total other revenue--------
Total revenue831799753701
Gross profit763728692642
Total cost of revenue67716159
Total operating expense704620558535
Selling / general / administrative260230232233
Research & development206196179167
Depreciation / amortization80828089
Interest expense (income), net operating--------
Unusual expense (income)91417-13
Other operating expenses, total--------
Operating income127179195166
Interest income (expense), net non-operating-25-----24
Gain (loss) on sale of assets--------
Other--------
Income before tax104158170144
Income after tax929411592
Income tax, total12645551
Net income929411592
Total adjustments to net income--------
Net income before extra. items929411592
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items929411592
Inc. avail. to common incl. extra. items929411592
Diluted net income929411592
Dilution adjustment--------
Diluted weighted average shares228226226227
Diluted EPS excluding extraordinary itemsvalue per share0.400.420.510.41
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.760.530.530.37